Literature DB >> 24642460

Not simply misshapen red cells: multimolecular and cellular events in sickle vaso-occlusion.

Gregory M Vercellotti, John D Belcher.   

Abstract

Thromboinflammatory diseases result from the interactions of vascular endothelial cells, inflammatory cells, and platelets with cellular adhesion molecules, plasma proteins, and lipids. Tipping the balance toward a prothrombotic, proinflammatory phenotype results from multicellular activation signals. In this issue of the JCI, Li et al. explore the regulation of heterotypic neutrophil-platelet contacts in response to TNF-α-induced venular inflammation with relevance to sickle cell disease (SCD).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24642460      PMCID: PMC3973116          DOI: 10.1172/JCI75238

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice.

Authors:  D K Kaul; R P Hebbel
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease.

Authors:  C Pászty; C M Brion; E Manci; H E Witkowska; M E Stevens; N Mohandas; E M Rubin
Journal:  Science       Date:  1997-10-31       Impact factor: 47.728

3.  Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.

Authors:  Aslihan Turhan; Linnea A Weiss; Narla Mohandas; Barry S Coller; Paul S Frenette
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.

Authors:  R P Hebbel; O Yamada; C F Moldow; H S Jacob; J G White; J W Eaton
Journal:  J Clin Invest       Date:  1980-01       Impact factor: 14.808

5.  Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion.

Authors:  J D Belcher; P H Marker; J P Weber; R P Hebbel; G M Vercellotti
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

6.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

7.  Microvascular blood flow and stasis in transgenic sickle mice: utility of a dorsal skin fold chamber for intravital microscopy.

Authors:  Venkatasubramaniam S Kalambur; Hemchandra Mahaseth; John C Bischof; Miroslaw C Kielbik; Thomas E Welch; Asa Vilbäck; David J Swanlund; Robert P Hebbel; John D Belcher; Gregory M Vercellotti
Journal:  Am J Hematol       Date:  2004-10       Impact factor: 10.047

8.  Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential role for platelet activation in sickle cell vaso-occlusion.

Authors:  H A Brittain; J R Eckman; R A Swerlick; R J Howard; T M Wick
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

9.  High expression of human beta S- and alpha-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia.

Authors:  M E Fabry; F Costantini; A Pachnis; S M Suzuka; N Bank; H S Aynedjian; S M Factor; R L Nagel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910.

Authors:  J B Herrick
Journal:  Yale J Biol Med       Date:  2001 May-Jun
View more
  12 in total

Review 1.  2015 Clinical trials update in sickle cell anemia.

Authors:  Natasha Archer; Frédéric Galacteros; Carlo Brugnara
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

2.  Dimethyl fumarate increases fetal hemoglobin, provides heme detoxification, and corrects anemia in sickle cell disease.

Authors:  Sriram Krishnamoorthy; Betty Pace; Dipti Gupta; Sarah Sturtevant; Biaoru Li; Levi Makala; Julia Brittain; Nancy Moore; Benjamin F Vieira; Timothy Thullen; Ivan Stone; Huo Li; William E Hobbs; David R Light
Journal:  JCI Insight       Date:  2017-10-19

3.  Vitamin D Deficiency and Its Association with Inflammatory Markers, Lipid Profile and Regulatory T-cells in Pediatric Sickle Cell Disease Patients.

Authors:  Yesim Oztas; Selma Unal; Gulcin Eskandari; Lulufer Tamer; Nuriman Ozgunes
Journal:  Indian J Hematol Blood Transfus       Date:  2017-10-13       Impact factor: 0.900

4.  Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.

Authors:  Selma Unal; Ozlem Ozdemir; Ahmet Ata Ozcimen; Yesim Oztas
Journal:  Int J Hematol       Date:  2014-12-06       Impact factor: 2.490

Review 5.  Inflammatory targets of therapy in sickle cell disease.

Authors:  Amma Owusu-Ansah; Chibueze A Ihunnah; Aisha L Walker; Solomon F Ofori-Acquah
Journal:  Transl Res       Date:  2015-07-11       Impact factor: 7.012

6.  Updated Mechanisms of Sickle Cell Disease-Associated Chronic pain.

Authors:  Brianna Lutz; Steffen E Meiler; Alex Bekker; Yuan-Xiang Tao
Journal:  Transl Perioper Pain Med       Date:  2015-07-26

7.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

Review 8.  Sickle Cell Disease: Advances in Treatment.

Authors:  Renée V Gardner
Journal:  Ochsner J       Date:  2018

9.  Process and procedural adjustments to improve CD34+ collection efficiency of hematopoietic progenitor cell collections in sickle cell disease.

Authors:  Scott T Avecilla; Farid Boulad; Karina Yazdanbakhsh; Michel Sadelain; Patricia A Shi
Journal:  Transfusion       Date:  2021-06-23       Impact factor: 3.337

10.  Low-dose methotrexate in sickle-cell disease: a pilot study with rationale borrowed from rheumatoid arthritis.

Authors:  Silvia R Brandalise; Rosemary Assis; Angelo B A Laranjeira; José Andrés Yunes; Pedro O de Campos-Lima
Journal:  Exp Hematol Oncol       Date:  2017-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.